The objective of this study was to determine whether there are changes in platelet activation and rheology in patients with chronic venous insufficiency (CVI) and what their impact is on this disease. Anticoagulated peripheral venous blood collected from 21 patients with CVI and 13 normal control subjects in different bodily positions was incubated either with 0.5 μmol/L adenosine diphosphate (ADP) or without agonist and analyzed by whole blood flow cytometry. Soluble P-selectin was analyzed in obtained sera by enzyme-linked immunosorbent assay. Platelet count was determined by a whole blood analyzer. Circulating platelets were more reactive to stimulation with 0.5 μmol/L ADP in patients with CVI compared with control subjects. There was no statistically significant change in platelet activation without ADP and the level of soluble P-selectin as a function of posture. Under simulated venous hypertension, platelet accumulation was observed in patients with CVI. Patients with CVI had increased platelet reactivity and accumulation during orthostasis, suggesting this might be a contributory factor to CVI pathogenesis.
Get full access to this article
View all access options for this article.
References
1.
Duran W, Pappas PJ, Schmid-Schönbein GW: Micro-circulatory inflammation in chronic venous insufficiency: Current status and future directions. Micro-circulation7:S49-S58, 2000.
2.
Herouy Y, Trefzer D, Zimpfer U, et al: Matrix metalloproteinases and venous leg ulceration. Eur J Dermatol10:173-180, 2000 (review).
3.
Korthuis RJ, Unthank JL: Experimental model to investigate inflammatory process in chronic venous insufficiency. Microcirculation7(6 Pt 2):S13-S22, 2000.
4.
Li N, Hu H, Lindqrist M, et al: Platelet-leukocyte cross talk in whole blood. Arterioscler Thromb Vasc Biol20:2702-2708, 2000.
5.
The Consensus Group: Classification and grading of chronic venous disease in the lower limb: A consensus statement. Vasc Surg30:5-11, 1996.
6.
Blann AD, Steele C, McCollum CN: The influence of smoking on soluble adhesion molecules and endothelial cell markers. Thromb Res85:433-438, 1997.
7.
Verhaar MC, Beutler JJ, Gaillard CA, et al: Progressive vascular damage in hypertension is associated with increased levels of circulating P-selectin. J Hypertens16:45-50, 1998.
8.
Nomura S, Shouzu A, Omoto S, et al: Significance of chemokines and activated platelets in patients with diabetes. Clin Exp Immunol121:437-443, 2000.
9.
Yngen M, Ostenson CG, Li N, et al: Acute hyperglycemia increases soluble P-selectin in male patients with mild diabetes mellitus. Blood Coagul Fibrinolysis12:109-116, 2001.
10.
Varki NM, Varki A: Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: Rationale for clinical studies in humans. Semin Thromb Hemost28:53-66, 2002.
11.
Bazzoni G, Dejana E, Del Maschio A: Platelet-neutrophil interactions: Possible relevance in the pathogenesis and inflammation. Haematologica76:491-499, 1991.
12.
Nagata K, Tsuji T, Todoroki N, et al: Activated platelets induce superoxide anion release by monocytes and neutrophils through P-selectin (CD62). J Immunol151:3267-3273, 1993.
13.
Furie B, Furie BC, Flaumenhaft R: A journey with platelet P-selectin: The molecule basis of granule secretion, signaling, and cell adhesion. Thromb Haemost86:214-221, 2001.
14.
Kuijper PH, Gallardo TH, Lammers JW, et al: Platelet and fibrin deposition at the damaged vessel wall: Cooperative substrates for neutrophil adhesion under flow conditions. Blood89:166-175, 1997.
15.
Barry OP, Pratico D, Savani RC, et al: Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest102:136-144, 1998.
16.
Takase S, Bergan JJ, Schmid-Schönbein GW: Expression of adhesion molecules and cytokines on saphenous veins in chronic venous insufficiency. Ann Vasc Surg14:427-435, 2000.
17.
Frenette PS, Johnson RC, Hynes RO, et al: Platelets roll on stimulated endothelium in vivo: An interaction mediated by endothelial P-selectin. Proc Natl Acad Sci USA92:7450-7454, 1995.
18.
Frenette PS, Denis CV, Weiss L, et al: P-Selectin glycoprotein ligand 1 (PSGL1) is expressed on platelets and can mediate platelet endothelial interactions in vivo. J Exp Med191:1413-1422, 2000.
19.
Gross PL, Merrill-Skoloff G, Aab M, et al: Glyco-protein Ib and PSGL-1 serve as platelet-endothelial cell interaction during platelet rolling on stimulated postcapillary venules in vivo. Blood96:812a-812a, 2000 (abstract).
20.
Elstad MR, La Pine TR, Cowley FS, et al: P-selectin regulates platelet activating factor synthesis and phagocytosis by monocyte. J Immunol155:2109-2122, 1995.
21.
Michelson AD, Barnard MR, Krueger LA, et al: Evaluation of platelet function by flow cytometry. Method21:259-270, 2000.
22.
Semenov AV, Romanov YA, Loktionova SA, et al: Production of soluble P-selectin by platelets and endothelial cells. Biochemistry Moso64:1326-1335, 1999.
23.
He CF, Cherry WG, Arnold F: Postural vasoregulation and mediators of reperfusion injury in venous ulceration. J Vasc Surg25:647-653, 1997.
24.
Powell CC, Rohrer MJ, Barnard MR, et al: Chronic venous insufficiency is associated with increased platelet and monocyte activation and aggregation. J Vasc Surg30:844-853, 1999.
25.
Takase S, Schmid-Schönbein GW, Bergan JJ: Leukocyte activation in patients with venous insufficiency. J Vasc Surg30:148-156, 1999.
26.
Labropoulos N, Giannoukas AD, Delis K, et al: Where does venous reflux start?J Vasc Surg26:736-742, 1997.
27.
Giuffetti G, Mannario E, Paltriccia R, et al: Leukocyte activity in chronic venous insufficiency. Int Angiol13:312-316, 1994.
28.
Konstantopoulos K, Neelamegham S, Burns AR, et al: Venous levels of shear support neutrophil-platelet adhesion and neutrophil aggregation in blood via P-selectin and b2-integrin. Circulation98:873-882, 1998.
29.
Moyses C, Cederholm-Williams SA, Michel CC: Haemoconcentration and accumulation of white cells in the feet during venous stasis. Int J Microcirc Clin Exp5:311-320, 1987.
30.
Li N, Goodall AH, Hjemdahl P: Efficient flow cytometric assay for platelet-leukocyte aggregates in whole blood using fluorescence signal triggering. Cytometry35:154-161, 1999.
31.
Farady N, Scharpf RB, Dodd-o JM, et al: Leukocytes can enhance platelet-mediated aggregation and thromboxane release via interaction of P-selectin glycoprotein 1 with P-selectin. Anesthesiology94:145-151, 2001.
32.
Ritchie JL, Crawford VL, McNulty M, et al: Effect of tourniquet pressure and intra-individual variability on plasma fibrinogen, platelet P-selectin, and monocyte tissue factor. Clin Lab Haematol22:369-372, 2000.
33.
Leytin V, Mody M, Semple JW, et al: Quantification of platelet activation status by analyzing P-selectin expression. Biochem Biophys Res Commun273:565-570, 2000.
34.
Leytin V, Mody M, Semple JW, et al: Flow cytometric parameters for characterizing platelet activation by measuring P-selectin (CD62P) expression: Theoretical consideration and evaluation in thrombin-treated platelet population. Biochem Biophys Res Commun269:85-90, 2000.
35.
Savion N, Shenkman B, Tamarin I, et al: Transient adhesion refractoriness of circulating platelets under shear stress: The role of partial activation and microaggregate formation by suboptimal ADP concentration. Br J Haematol112:1055-1061, 2001.
